To further determine the clinicopathological significance of CSE1L in pancreatic cancer, we performed IHC analysis of CSE1L in a tissue microarray that included an independent set of 90 cases of pancreatic cancer tissues. The gene discussed is CSE1L; the disease is pancreatic neoplasm.